Thrombomodulin (TM), a high affinity thrombin receptor present on endothelial cell membrane, plays an important role as a natural anticoagulant. It acts as a cofactor of thrombin-catalyzed activation of protein C, and inhibits the procoagulant functions of thrombin. TM is also located in other cells (keratinocytes, osteoblasts, macrophages, …) where it might be involved in cell differentiation or in inflammation. In the presence of cytokines, activated neutrophils and macrophages, endothelial TM is cleaved enzymatically, releasing soluble fragments which circulate in the blood and are eliminated in urine. Plasma TM level (pTM) can be measured using a two-site enzyme-linked immunosorbent assay (ELISA). pTM level is regarded as a molecular marker reflecting injury of endothelial cells. It is often increased in case of diffuse endothelial damage as in disseminated intravascular coagulation, diabetic microangiopathy, Plasmodium falciparum and rickettsial infections. pTM is also a predictive marker of hypertensive complications in pregnancy. In several systemic inflammatory diseases, pTM levels are correlated to the activity of the disease.
EsmonCT.Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface.FASEB J1995; 9: 946–955.
2.
BourinMC, Lundgren-AkerlundE, LindahlU.Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan.J Biol Chem1990; 265: 15424–15431.
3.
WenDZ. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene.Biochemistry1987; 26: 4350–4357.
4.
ConwayEd, PollefeytS, CollenD, MosonyiMS.The amino-terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.Blood1997; 89: 652–661.
5.
GysinJ. Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes.Mol Biochem Parasitology1997; 88: 267–271.
6.
EsmonCT, OwenWG.Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.Proc Natl Acad Sci USA1981; 78: 2249–2252.
7.
BajzarL, ManuelR, NesheimM.Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor.J Biol Chem1995; 270: 14477–14484.
8.
GreyST, HancockWW.A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.J Immunol1996; 156: 2256–2263.
9.
EsmonCT, FudukomeK.Cellular regulation of the protein C pathway.Semin Cell Biol1995; 6: 259–268.
10.
BoehmeMWJ. Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.Immunology1996; 87: 134–140.
11.
ImadaS. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays.Dev Biol1990; 140: 113–122.
12.
RaifeTJ. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation.J Clin Invest1994; 93: 1846–1851.
13.
SenetP. Thrombomodulin, a functional surface protein on human keratinocytes, is regulated by retinoic acid.Arch Dermatol1997; 289: 151–157.
14.
BoffaMC.Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker.Haemostasis1996; 26 (Suppl 4): 233–243.
15.
MaruyamaI, BellCE, MajerusPW.Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.J Cell Biol1985; 101: 363–371.
16.
BoffaMC. Thrombomodulin in the central nervous system.Nouv Rev Fr Hematol1991; 33: 423–429.
17.
BoffaMC, BurkeB, HaudenschildCC.Preservation of thrombomodulin antigen on vascular and extravascular surfaces.J Histochem Cytochem1987; 35: 1267–1276.
18.
PrunaA, PeyriN, BerardM, BoffaMC.Thrombomodulin is synthesized by human mesangial cells.Kidney Int1997; 51: 687–693.
19.
McCachrenSS, DiggsJ, WeinbergJB, DittmanWA.Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages.Blood1991; 78: 3128–3132.
20.
ConwayEM, NowakowskiB, Steiner-MosonyiM.Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation.Blood1992; 80: 1254–1263.
21.
MaillardC. Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane.Endocrinology1993; 133: 668–674.
22.
PindonA, HantaiD, Jandrot-PerrusM, FestoffBW.Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes.Glia1997; 19: 259–268.
23.
CalnekDS, GrinnellBW.Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor.Exp Cel Res1998; 238: 294–298.
24.
IshiiH, MajerusPW.Thrombomodulin is present in human plasma and urine.J Clin Invest1985; 76: 2178–2181.
25.
IshiiH, UchiyamaH, KazamaM.Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells.Thromb Haemost1991; 65: 618–623.
26.
AbeH. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro.J Lab Clin Med1994; 123: 874–881.
27.
TakanoS, KimuraS, OhdamaS, AokiN.Plasma thrombomodulin in health and diseases.Blood1990; 76: 2024–2029.
28.
KodamaS. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies.Clin Chim Acta1990; 192: 91–99.
29.
IshiiH. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies.Thromb Haemost1990; 63: 157–162.
30.
AmiralJ. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma.Hybridoma1994; 13: 205–213.
31.
BoffaMC. Variations of plasma thrombomodulin level due to sex and age.Blood (Abstract) 1991; 78: S1, 221.
32.
BlannAD, DalyRJ, AmiralJ.The influence of age, gender and ABO blood groups on soluble endothelial cell markers and adhesion molecules.Br J Haem1996; 92: 498–500.
33.
De MoerlooseP, MermillodN, AmiralJ, ReberG.Thrombomodulin levels during normal pregnancy at delivery and in post-partum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor.Thromb Haemost1998; 79: 554–556.
34.
BoffaMC. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension.Thromb Haemost1998; 79: 1092–1095.
35.
CacoubP. Plasma levels of thrombomodulin in pulmonary hypertension.Am J Med1996; 101: 160–164.
36.
QuehenbergerP. Increased level of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.Thromb Haemost1996; 76: 729–734.
37.
HemmerCJ. Elevated thrombomodulin plasma levels as a result of endothelial involvement in Plasmodium falciparum malaria.Thromb Haemost1994; 72: 457–464.
38.
GeorgeF. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever.Blood1993; 82: 2109–2116.
39.
TanakaA. Increased thrombomodulin values in plasma of diabetic men with microangiopathy.Clin Chem1991; 37: 269–272.
40.
ReverterJL. Thrombomodulin and induced tissue factor expression on monocytes are markers of diabetic microangiopathy: a prospective study on haemostasis and lipoproteins in insulin-dependent diabetes mellitus.Am J Hematol1997; 56: 93–99.
41.
AsakuraH. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.Am J Hematol1991; 38: 281–287.
42.
GandoS, KameueT, NanzakiS, NakanishiY.Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome.Thromb Res1995; 80: 519–526.
WadaH. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.Am J Hematol1992; 39: 20–24.
45.
BontisJ. Maternal plasma level of thrombomodulin is increased in mild preeclampsia.Eur J Obstet Gynecol1995; 60: 139–141.
46.
HsuCD, CopelJA, HongSF, ChanDW.Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension.Obstet Gynecol1995; 86: 897–899.
47.
BoldtJ. Endothelial-related coagulation in cardiac surgery.Br J Anaesth1995; 74: 174–179.
48.
HoshiK. Plasma thrombomodulin levels in coronary sinus blood in patients with coronary artery disease.Blood Coagul Fibrinolysis1995; 6: 129–132.
49.
SeigneurM. Levels of plasma thrombomodulin are increased in atheromatous arterial disease.Thromb Res1993; 71: 423–431.
50.
BlannAD. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.Eur J Clin Invest1997; 27: 916–921.
51.
SeigneurM. Circulating endothelial markers and ischemic status in peripheral occlusive arterial disease.Nouv Rev Fr Hematol1995; 37: 171–173.
52.
KarlheinzP. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin and thrombomodulin.Arteriosc Thromb Vasc Biol1997; 17: 505–512.
53.
De CaterinaR. Soluble vascular adhesion molecule-1 as a biohumoral correlate of atherosclerosis.Arteriosc Thromb Vasc Biol1997; 17: 2646–2654.
54.
JanssonJH, BomanK, BrannstrommM, NilssonTK.High concentrations of thrombomodulin in plasma is associated with hemorrhage prospectively studied in patients on long-term anti-coagulant treatment.Circulation1997; 96: 2938–2943.
55.
JanssonJH, BomanK, BrannstrommM, NilssonTK.Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant.Eur Heart J1996; 17: 1503–1505.
56.
TakayaM. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus.Clin Exp Rheumatol1991; 9: 495–499.
57.
KarmochkineM. Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies letter.Blood1992; 79: 837–838.
58.
KawakamiM. Plasma thrombomodulin and α2-plasmin inhibitorplasmin complex are elevated in active systemic lupus erythematosus.J Rheumatol1992; 19: 1704–1709.
59.
OdhamaS. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases.Am J Clin Pathol1994; 101: 109–113.
60.
OdhamaS, YoshizawaY, KubotaT, AokiN.Plasma thrombomodulin as an indicator of thromboembolic disease in systemic lupus erythematosus.Int J Cardiol1994; 47: S1–S6.
61.
BoehmeMWJ. Serum thrombomodulin: a novel marker of disease activity in systemic lupus erythematosus.Arthritis Rheum1994; 27: 572–577.
62.
MatsudaJ. Clinical significance of the venous occlusion test on systemic lupus erythematosus patients with a focus on changes in blood levels of tissue plasminogen activator, von Willebrand factor antigen, and thrombomodulin.Acta Haematol1992; 88: 22–26.
63.
AlessiMC. Venous occlusion does not induce the release of thrombomodulin from endothelial cells in patients with thromboembolic disease.Thromb Haemostas1992; 68: 483–484.
64.
KotajimaL, AotsukaS, SatoT.Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases.Clin Exp Rheumatol1997; 15: 59–65.
65.
MerciéP, SeigneurM, CouriC.Plasma marker of vascular damage in systemic sclerosis.J Rheumatol1995; 22: 1444–1445.
66.
OdhamaS, MatsubaraO, AokiN.Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries.Chest1994; 106: 666–671.
67.
BoehmeMWJ. Relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.Am J Med1996; 101: 387–394.
